These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17062664)

  • 21. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
    Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
    Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
    Qiao H; Hung W; Tremblay E; Wojcik J; Gui J; Ho J; Klassen J; Campling B; Elliott B
    J Cell Biochem; 2002; 86(4):665-77. PubMed ID: 12210733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma.
    Miller CT; Lin L; Casper AM; Lim J; Thomas DG; Orringer MB; Chang AC; Chambers AF; Giordano TJ; Glover TW; Beer DG
    Oncogene; 2006 Jan; 25(3):409-18. PubMed ID: 16186806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
    Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
    Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
    Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways.
    Leibowitz-Amit R; Tsarfaty G; Abargil Y; Yerushalmi GM; Horev J; Tsarfaty I
    Cancer Res; 2006 Sep; 66(17):8687-97. PubMed ID: 16951184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma.
    Xie LQ; Bian LJ; Li Z; Li Y; Li ZX; Li B
    Ann Surg Oncol; 2010 Jul; 17(7):1927-36. PubMed ID: 20131016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
    Porte H; Triboulet JP; Kotelevets L; Carrat F; Prévot S; Nordlinger B; DiGioia Y; Wurtz A; Comoglio P; Gespach C; Chastre E
    Clin Cancer Res; 1998 Jun; 4(6):1375-82. PubMed ID: 9626453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion.
    Davies G; Jiang WG; Mason MD
    Clin Cancer Res; 2001 Oct; 7(10):3289-97. PubMed ID: 11595727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
    Liang H; O'Reilly S; Liu Y; Abounader R; Laterra J; Maher VM; McCormick JJ
    Int J Oncol; 2004 May; 24(5):1057-67. PubMed ID: 15067326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis.
    Krishnadath KK; Tilanus HW; van Blankenstein M; Hop WC; Kremers ED; Dinjens WN; Bosman FT
    J Pathol; 1997 Jul; 182(3):331-8. PubMed ID: 9349237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Slug regulates proliferation and invasiveness of esophageal adenocarcinoma cells in vitro and in vivo.
    Zhang K; Zhang S; Jiao X; Wang H; Zhang D; Niu Z; Shen Y; Lv L; Zhou Y
    Med Oncol; 2011 Dec; 28(4):1089-100. PubMed ID: 20730573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifies cyclin-dependent kinase 6 at both genomic and protein expression levels.
    van Dekken H; van Marion R; Vissers KJ; Hop WC; Dinjens WN; Tilanus HW; Wink JC; van Duin M
    Genes Chromosomes Cancer; 2008 Aug; 47(8):649-56. PubMed ID: 18438866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocyte growth factor and its receptor Met are induced in crescentic glomerulonephritis.
    Rampino T; Gregorini M; Camussi G; Conaldi PG; Soccio G; Maggio M; Bottelli A; Dal Canton A
    Nephrol Dial Transplant; 2005 Jun; 20(6):1066-74. PubMed ID: 15784643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells.
    Matteucci E; Ridolfi E; Desiderio MA
    Cell Mol Life Sci; 2006 Sep; 63(17):2016-26. PubMed ID: 16909210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.